Conditions: Coronary Artery Disease
Keywords: coronary artery disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 58
Healthy volunteers: no

Brief summary:
This was a mechanistic study in patients with coronary artery disease on the effects of Serelaxin on micro- and macrovascular function.

Detailed description:
double blind, randomized, parallel group, placebo controlled study

Arms:
arm 1: Serelaxin was administered at a dose of 30 μg/kg/24h by intravenous infusion for 48 hours arm 2: Placebo was administered by intravenous infusion for 48 hours

Interventions: intervention 1: Serelaxin intervention 2: Placebo
Intervention descriptions: intervention 1: Serelaxin solution diluted in 5% glucose volume/volume (v/v) solution intervention 2: 5% v/v glucose solution

Protocol document: